医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Q-Lab Announces Launch of Korean Language Website

2012年10月05日 AM03:11
このエントリーをはてなブックマークに追加


 

CLEVELAND

Q-Lab, the worldwide leader in accelerated weathering test equipment and outdoor exposure test services, is pleased to announce the launch of a new Korean language website at www.q-lab.com/ko-kr.

The website has ten times the content of our original English site, and is also available in Chinese, Spanish, German, Italian, and French. More languages will be coming soon. Customers from Korea can now visit and learn about weathering, research our test equipment and exposure services, or search relevant industry standards in our extensive database.

Users can also find out about Q-Lab’s upcoming seminars, or simply contact our local representatives in Korea. A new applications section was created for a dozen different industries. In addition, anyone performing an outdoor or accelerated test at one of our facilities in Florida, Arizona or Germany can check their results online, through a portal on our main page.

Everything you need to know about weathering is now available in Korean.

Discover more information about Q-Lab’s accelerated weathering testers or outdoor exposure services by contacting us at info@q-lab.com, and make sure to visit our website at www.q-lab.com.

Will your product last outdoors? Don’t guess when you can test!

CONTACT

For additional editorial information contact:
Q-Lab Corporation
Karin
Strippel, Marketing Communications Specialist, 440-835-8700
kstrippel@q-lab.com
or
For
technical inquiries contact:
Q-Lab Corporation
800 Canterbury
Road
Cleveland, OH 44145 USA
Tel: 440-835-8700
Fax:
440-835-8738

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表